Suppr超能文献

佩罗尼氏病与纤维化斑块中纤溶酶原激活物抑制剂增加有关。

Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque.

作者信息

Davila Hugo H, Magee Thomas R, Zuniga Freddi I, Rajfer Jacob, Gonzalez-Cadavid Nestor F

机构信息

Department of Urology, University of California, Los Angeles, School of Medicine, Los Angeles, California, USA.

出版信息

Urology. 2005 Apr;65(4):645-8. doi: 10.1016/j.urology.2005.01.010.

Abstract

OBJECTIVES

To investigate whether tissue expression of plasminogen activator inhibitor type 1 (PAI-1) is increased in the fibrotic plaque of human Peyronie's disease (PD). Increased tissue levels of PAI-1, an inhibitor of both fibrinolysis and collagenolysis, have been found in a variety of fibrotic conditions. Recently, it was reported that PAI-1 expression was also increased in the fibrotic plaque of an animal model of PD induced by the injection of fibrin into the tunica albuginea (TA) of the penis.

METHODS

Tissue (n = 10/group) and cells (n = 4/group) obtained from the penile TA plaque of patients with PD or from normal TA were subjected to RNA extraction and real-time reverse transcriptase-polymerase chain reaction. Tissues were also analyzed by immunohistochemistry (n = 8/group) for the detection of PAI-1 expression at the transcription and protein levels.

RESULTS

A significant 3.5-fold to 16-fold increase was found in both PAI-1 mRNA and protein levels in the human PD plaque and the respective fibroblast cultures compared with the normal non-PD TA.

CONCLUSIONS

The observed increase in PAI-1 in the human PD plaque agrees with what has been observed in the rat and suggests that PAI-1 may be a key pro-fibrotic factor in the development of human PD.

摘要

目的

研究1型纤溶酶原激活物抑制剂(PAI-1)的组织表达在人类佩罗尼氏病(PD)的纤维化斑块中是否增加。在多种纤维化疾病中已发现,作为纤维蛋白溶解和胶原溶解的抑制剂,PAI-1的组织水平升高。最近有报道称,在通过向阴茎白膜(TA)注射纤维蛋白诱导的PD动物模型的纤维化斑块中,PAI-1的表达也增加。

方法

从PD患者的阴茎TA斑块或正常TA获取组织(每组n = 10)和细胞(每组n = 4),进行RNA提取和实时逆转录-聚合酶链反应。还通过免疫组织化学(每组n = 8)对组织进行分析,以检测转录和蛋白质水平的PAI-1表达。

结果

与正常非PD的TA相比,在人类PD斑块和相应的成纤维细胞培养物中,PAI-1的mRNA和蛋白质水平均显著增加了3.5倍至16倍。

结论

在人类PD斑块中观察到的PAI-1增加与在大鼠中观察到的情况一致,表明PAI-1可能是人类PD发展中的关键促纤维化因子。

相似文献

1
Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque.
Urology. 2005 Apr;65(4):645-8. doi: 10.1016/j.urology.2005.01.010.
4
Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.
J Urol. 2003 Jul;170(1):281-4. doi: 10.1097/01.ju.0000070860.78370.08.
5
7
Basic fibroblast growth factor expression in Peyronie's disease.
J Urol. 2001 Feb;165(2):419-23. doi: 10.1097/00005392-200102000-00016.
8
Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Fertil Steril. 2004 Jun;81(6):1657-64. doi: 10.1016/j.fertnstert.2003.12.022.
10

引用本文的文献

1
Acute Phase Peyronie's Disease: Where Do We Stand?
Cureus. 2024 Aug 17;16(8):e67054. doi: 10.7759/cureus.67054. eCollection 2024 Aug.
2
Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review.
Int J Impot Res. 2024 Dec;36(8):801-808. doi: 10.1038/s41443-024-00845-2. Epub 2024 Mar 7.
3
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease.
Int J Mol Sci. 2023 Jun 14;24(12):10133. doi: 10.3390/ijms241210133.
5
New insights into the pathogenesis of Peyronie's disease: A narrative review.
Chronic Dis Transl Med. 2020 Jul 27;6(3):165-181. doi: 10.1016/j.cdtm.2020.06.001. eCollection 2020 Sep.
6
A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie's disease.
World J Urol. 2020 Feb;38(2):253-261. doi: 10.1007/s00345-019-02815-6. Epub 2019 Jun 12.
7
Intralesional collagenase in the management of Peyronie's disease: current best practice.
Ther Adv Urol. 2018 Feb 8;10(4):139-153. doi: 10.1177/1756287218755020. eCollection 2018 Apr.
9
Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.
Nat Rev Urol. 2010 Apr;7(4):215-21. doi: 10.1038/nrurol.2010.24. Epub 2010 Mar 9.
10
Pharmacological Management of Peyronie's Disease.
Drugs. 2007;67(4):527-45. doi: 10.2165/00003495-200767040-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验